Amitriptyline

  • 1 lab in 1 country
  • Humans2

Outcomes

1

MeReCAE index

upin silico1

1 study
  1. Amitriptyline increases MeReCAE index in silico.

    “A more important shift toward higher MeReCAE values was observed when amitriptyline and asenapine were added to the drug regimen of patients.”

    In silicovirtual addition to patient drug regimens

    A NEW MEDICATION-RELATED CUMULATIVE ANTICHOLINERGIC EXPOSURE INDEX EVALUATING RISK OF COGNITIVE IMPAIRMENT

    GSA 2024 abstract31 Dec 2024

More on MeReCAE index

Associations

1

Alzheimer's disease and related dementia

downin humans1

1 study
  1. Amitriptyline lowers the risk of Alzheimer's disease and related dementia in humans (IRR 0.8; 95% CI 0.8–0.9).

    “Some protective phenothiazines in our dataset included amitriptyline (IRR 0.8; 95%CI 0.8‐0.9)”

    Humans

    Experimental and real‐world evidence supporting the repurposing of drugs targeting proteotoxicity and inflammation to treat Alzheimer's disease

    AAIC 2025 abstract23 Dec 2025

More on Alzheimer's disease and related dementia

Latest

Nov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months